Semi-remote production of [64Cu]CuCl2 and preparation of high specific activity [64Cu]Cu-ATSM for PET studies

Radiochimica Acta

Volumn 93, Issue 4, 2005, Pages 239-244

  Szajek, L P ^a   Meyer, W ^a   Plascjak, P ^a   Eckelman, W C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

ATSM; Automation; Cu 64; PET imaging; Specific activity; Tangential target

Indexed keywords

EID: 17744395332     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.93.4.239.64070     Document Type: Article

References (18)

1. Blower, P. J., Lewis, J. S., Zweit, J.: Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl. Med. Biol. 23, 957 (1996).
2. Lewis, J. S., Laforest, R., Buettner, T. L., Song, S.-K., Fujibayahsi, Y., Connett, J. M., Welch, M. J.: Copper-64-diacetyl-bis(N4- methylthiosemicarbazone): an agent for radiotherapy. P. Natl. Acad. Sci. USA 98(3), 1206.
3. 64Ni targets for positron emission tomography. Appl. Radiat. Isot. 42, 193 (1991).
4. 64Cu at a small cyclotron. Appl. Radiat. Isot. 44, 575 (1993).
5. 64Cu using a biomedical cyclotron. Nucl. Med. Biol. 24, 35 (1997).
6. 64Cu using a 12 MeV cyclotron. Nucl. Med. Biol. 30, 535 (2003).
7. 67 Cu process. Appl. Radiat. Isot. 59, 343 (2003).
8. Aft, R. L., Lewis, J. S., Zhang, F., Kim, J., Welch, M. J.: Enhancing target radiotheraphy by copper(II)diacetyl-bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose. Cancer Res. 63, 5496 (2003).
9. 60Cu-ATSM: relationship to therapeutic response - a preliminary report. Int. J. Radiation Oncology Biol. Phys. 55(5), 1233 (2003).
10. Lewis, J. S., Herrero, P., Sharp, T. L., Engelbach, J. A., Fujibayashi, Y., Laforest, R., Kovacs, A., Gropler, R. J., Welch, M. J.: Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N4- methylthiosemicarbazone). J. Nucl. Med. 43(11), 1557 (2002).
11. Chao, K. S., Bosch, W. R., Mutic, S., Lewis, J. S., Dehdashti, F., Mintun, M. A., Dempsey, J. F., Perez, C. A., Purdy, J. A., Welch, M. J.: A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int. J. Radiation Oncology Biol. Phys. 49(4), 1171 (2001).
12. 62Cu labeled diacetyl-bis-(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Ann. Nucl. Med. 14(5), 323 (2000).
13. 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J. Nucl. Med. 40(1), 177 (1999).
14. Petering, H. G., Buskirk, H. H., Underwood, G. E.: The anti-tumor activity of 2-keto-3-ethoxybutyraldehyde bis(thiosemicarbazone) and related compounds. Cancer Research 24, 367 (1964).
15. Obata, A., Yoshimi, E., Waki, A., Lewis, A., Oyama, N., Welch, M. J., Saji, H., Yonekura, Y., Fujibayashi, Y.: Retention mechanism of hypoxia nuclear imaging/radiotherapeutic agent Cudiacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells. Ann. Nucl. Med. 15(6), 499 (2001).
16. Fujibayashi, Y., Taniuchi, H., Yonekura, Y., Ohtani, H., Konishi, J., Yokoyama, A.: Copper-62-ATSM: a new hypoxia imaging agent with high membrane permability and low redox potential. J. Nucl. Med. 38(7), 1155 (1997).
17. 64Cu-ATSM: a comparison study with FDG. Nucl. Med. Biol. 30, 529 (2003).
18. Fujibayashi, Y., Cutler, C. S., Anderson, C. J., McCarthy, D. W., Jones, L. A., Sharp, T., Yonekura, Y., Welch, M. J.: Comparative studies of Cu-64 ATSM and C-11 acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. Nucl. Med. Biol. 26, 117 (1999).